Strategic Investment
We belong to a new breed of biotech investor that strongly believes in the concept of “smart money”. We combine our capital with our collaborative drug development team to deliver a unique investment formulation.
We believe that providing the capital and expertise at this crucial moment is key to allowing new inventions and technologies to show their true potential.
KreaMedica invests in fast-growing biotechnology companies that develop innovative drugs or disruptive technologies. We focus on biotech companies whose products address areas of significant unmet medical needs and thus have above-average sales and profit growth potential. Furthermore, we focus on the earlier phases of development, where most of the funding challenges exist.
